Palisade Bio (PALI) Interest & Investment Income (2010 - 2021)
Palisade Bio (PALI) reported Interest & Investment Income of $3917.0 for Q1 2021, down 70.52% year-over-year from $13289.0 in Q1 2020, and down 30.02% quarter-over-quarter from $5597.0 in Q4 2020.
Palisade Bio (PALI) Interest & Investment Income (2010 - 2021) Analysis & Trends
Palisade Bio (PALI) has 12 years of Interest & Investment Income data on file, last reported at $3917.0 in Q1 2021.
- Interest & Investment Income for Q1 2021 came in at $3917.0, down 70.52% year-over-year; the trailing twelve-month figure through Mar 2021 was $24160.0 (down 53.56% YoY), and the FY2020 annual result was $33532.0, down 50.49% from the prior year.
- Interest & Investment Income retreated to $3917.0 in Q1 2021 per PALI's latest filing, from $5597.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $29000.0 in Q1 2019 and troughed at $3917.0 in Q1 2021.
- A 5-year average of $14954.6 and a median of $15234.0 in 2019 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2017 and 2021: Interest & Investment Income jumped 87.53% in 2017, then sank 70.52% in 2021.
- A 5-year view of Interest & Investment Income shows it stood at $17274.0 in 2017, then jumped by 38.35% to $23898.0 in 2018, then plunged by 47.09% to $12645.0 in 2019, then tumbled by 55.74% to $5597.0 in 2020, then slumped by 30.02% to $3917.0 in 2021.
- Business Quant data shows PALI's Interest & Investment Income at $3917.0 in Q1 2021, $5597.0 in Q4 2020, and $7731.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Palisade Bio | 391.02 Mn | 261.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 3,917.00 |
| Dec 31, 2020 | 5,597.00 |
| Sep 30, 2020 | 7,731.00 |
| Jun 30, 2020 | 6,915.00 |
| Mar 31, 2020 | 13,289.00 |
| Dec 31, 2019 | 12,645.00 |
| Sep 30, 2019 | 15,234.00 |
| Jun 30, 2019 | 10,852.00 |
| Mar 31, 2019 | 29,000.00 |
| Dec 31, 2018 | 23,898.00 |
| Sep 30, 2018 | 17,619.00 |
| Jun 30, 2018 | 19,514.00 |
| Mar 31, 2018 | 17,749.00 |
| Dec 31, 2017 | 17,274.00 |
| Sep 30, 2017 | 18,099.00 |
| Jun 30, 2017 | 14,013.00 |
| Mar 31, 2017 | 20,883.00 |
| Dec 31, 2016 | 16,973.00 |
| Sep 30, 2016 | 17,293.00 |
| Jun 30, 2016 | 13,433.00 |